22157.jpg
Medical Devices Sector: 2023 Update on Contrast Agents Pipeline Reveals Key Companies and Emerging Technologies
January 23, 2024 08:13 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report...
prfx.png
PainReform CEO to Present at Aegis Virtual Conference on May 4th
May 02, 2023 08:30 ET | PainReform Ltd
TEL AVIV, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
download.png
Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent With Claims Covering OPNT003 for the Treatment of Opioid Overdose
August 02, 2022 16:05 ET | Opiant Pharmaceuticals
SANTA MONICA, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (Opiant) (NASDAQ: OPNT) today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of...
Orchestra.jpg
Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2
July 05, 2022 08:00 ET | Orchestra BioMed
      Strategic collaboration with Medtronic to develop BackBeat Cardiac Neuromodulation Therapy™ as potential integrated hypertension treatment for cardiac pacemaker patients Investors in $110...
XOMA-Logo-Final.png
XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters’ Option
April 12, 2021 07:30 ET | XOMA Corporation
Raised aggregate gross proceeds of $40 million Depositary shares represent an interest in 8.375% Series B Cumulative Perpetual Preferred Stock EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE)...
XOMA-Logo-Final.png
XOMA Prices $35 Million Offering of Depositary Shares
April 06, 2021 19:02 ET | XOMA Corporation
EMERYVILLE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of...
XOMA-Logo-Final.png
XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock
April 05, 2021 16:05 ET | XOMA Corporation
EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of...
XOMA-Logo-Final.png
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering
December 21, 2020 17:00 ET | XOMA Corporation
EMERYVILLE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced underwritten registered public...
XOMA-Logo-Final.png
XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock
December 10, 2020 18:22 ET | XOMA Corporation
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the pricing of its underwritten registered public offering of 880,000...
XOMA-Logo-Final.png
XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock
December 10, 2020 07:52 ET | XOMA Corporation
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of shares...